Cargando…
Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
Prostate cancer is the most common malignancy in men in the United States. While androgen deprivation therapy results in tumor responses initially, there is relapse and progression to metastatic castration-resistant prostate cancer. Currently, all prostate cancer patients receive essentially the sam...
Autores principales: | Ramroop, Johnny R., Stein, Mark N., Drake, Justin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820335/ https://www.ncbi.nlm.nih.gov/pubmed/29503809 http://dx.doi.org/10.3389/fonc.2018.00028 |
Ejemplares similares
-
A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019) -
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
por: Wang, Wanyan, et al.
Publicado: (2021) -
Integrating phosphoproteomics into the clinical management of prostate cancer
por: Cheng, Larry C., et al.
Publicado: (2017) -
Global Inequities in Precision Medicine and Molecular Cancer Research
por: Drake, Thomas M., et al.
Publicado: (2018) -
Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
por: Kamran, Sophia C., et al.
Publicado: (2021)